What are the diagnostic tests for pulmonary embolism (PE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pulmonary embolism (PE) is best diagnosed through a combination of clinical assessment and diagnostic tests, with the initial evaluation typically including a D-dimer blood test, followed by imaging tests such as CT pulmonary angiography (CTPA) for patients with moderate to high clinical suspicion. The diagnostic approach for PE involves stratifying patients into different risk categories based on their pretest probability of having the disease.

  • For patients with low pretest probability, the Pulmonary Embolism Rule-Out Criteria (PERC) should be applied, and if all criteria are met, a plasma d-dimer test is not necessary 1.
  • For patients with intermediate pretest probability, a plasma d-dimer test is warranted, and if the result is normal, imaging studies are not indicated 1.
  • For patients with high pretest probability, imaging studies such as CTPA should be performed, with ventilation-perfusion (V/Q) lung scanning used as an alternative when CTPA is unavailable or contraindicated 1. The choice of test depends on the patient's clinical presentation, risk factors, and contraindications to specific testing modalities.
  • CTPA is the preferred method of diagnosis when available and there is no contraindication to radiographic contrast dye 1.
  • V/Q scanning is an alternative for patients who cannot undergo CT, such as those with kidney disease or contrast allergies 1.
  • Lower extremity ultrasound may be performed to look for deep vein thrombosis (DVT), which is often the source of pulmonary emboli 1.
  • Bedside echocardiography can detect right heart strain indicative of significant PE in unstable patients or when other tests are unavailable 1. Overall, the diagnostic approach for PE should be guided by the patient's clinical presentation and risk factors, with the goal of minimizing unnecessary testing and reducing the risk of morbidity and mortality associated with the disease 1.

From the Research

Diagnostic Tests for Pulmonary Embolism (PE)

The diagnostic tests for pulmonary embolism (PE) include:

  • Computed Tomographic Pulmonary Angiography (CTPA) 2, 3, 4, 5
  • Ventilation-Perfusion (V/Q) scanning 2, 3, 6
  • Single Photon Emission Tomography (SPECT) V/Q scanning 2, 6
  • Perfusion lung scan 3
  • D-dimer testing 6
  • Lower limb venous compression ultrasound 6

Characteristics of Diagnostic Tests

  • CTPA is the most sensitive test for the diagnosis of PE 2
  • CTPA has a high sensitivity but may be associated with significant radiation exposure 2, 4
  • V/Q scanning has a high specificity but a low sensitivity 3
  • SPECT V/Q scanning has increased diagnostic accuracy compared to V/Q scanning 2, 6
  • D-dimer testing can safely rule out PE in patients with low or intermediate clinical probability 6

Diagnostic Algorithms

  • Diagnostic algorithms using CTPA or V/Q scanning have proven to be comparably safe to exclude the diagnosis of PE 2
  • The use of clinical scoring systems and D-dimer testing can enhance the yield of diagnostic testing 2, 6
  • CTPA is the recommended imaging technique in patients with high clinical probability or positive D-dimers 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pulmonary embolism: lung scan and computed tomography.

Italian heart journal : official journal of the Italian Federation of Cardiology, 2005

Research

[Diagnosis of pulmonary embolism].

La Revue de medecine interne, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.